NorthWest Biotherapeutics Inc (NWBO)

[WojD40]

I see the logic and prudence behind your argument, but I disagree that the current share price dictates the maximum amount someone might pay for the company. We are in a place where the share price is entirely divorced from the value of the company.

There was a news story a few years ago about a piano tuner who discovered half a million pounds worth of gold coins hidden underneath the keys. The piano had been purchased for a few hundred quid. Would you say that - having discovered the treasure - no one would pay more that £100k (the price of a new Concert Grand) because it was recently a bargain?

An enterprise is worth whatever anyone is willing to pay for it, and I believe we are hugely and artificially undervalued already (my guess is by a factor of 10). There is zero chance that NWBO or any of their potential suitors haven't done the math on what the company's potential worth is. Projected revenue times some multiple. Current share price is irrelevant to those negotiations...brutal as they might be.

If The Buyer was worried about the optics of paying some ungodly multiple of an OTC share price, and wanted to 'work with the company' to raise the price, they could have started this process two years ago without falling foul of any embargo. I find it hard to imagine how such an informal arrangement could be reached, or why NWBO would agree to it, seeing as they could finance operations themselves and avoid being tied to a single suitor for the most vulnerable part of the process (Data Lock to Approval and Manufacturing at Scale). I wouldn't want some Swiss giant breathing down my neck for this part.

The market is making a mistake in its pricing of these shares. This will not influence the price paid in a buyout, should it occur.

I'm gonna go out on a limb and say KIPK's wonderfully relentless posts about a '25B-50B valuation coming' is spot on. BP offered 25, Linda countered with 50. We'll see where we end up.